Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis
- PMID: 20213809
- PMCID: PMC3304541
- DOI: 10.1002/art.27379
Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis
Abstract
Objective: To determine the association of normal numbers of end row loops (ERLs) in nailfold capillaries at the time of diagnosis of juvenile dermatomyositis (DM) with clinical findings in untreated children with the disease and to identify predictors of the development of decreased numbers of ERLs.
Methods: Clinical and laboratory data from 80 untreated children with juvenile DM were collected. ERL numbers were recorded at the time of diagnosis and at 24 months and 36 months thereafter. The 12 children who had normal ERLs at diagnosis were compared with the remaining 68 children. Outcomes included the duration of untreated disease, the duration of treatment with immunosuppressive medications, family medical history, Disease Activity Score (DAS) for juvenile DM, creatinine phosphokinase level, aldolase level, absolute number of CD3-CD56+/16+ natural killer cells, and von Willebrand factor antigen level. Cross-sectional and longitudinal analyses were performed.
Results: At diagnosis, children with normal ERLs had a shorter duration of untreated disease (P = 0.03) and a lower skin DAS (P = 0.045). Over time, an increased likelihood of having decreased numbers of ERLs was associated with a longer duration of untreated disease and with a higher skin DAS.
Conclusion: The presence of a normal number of ERLs in juvenile DM appears to be associated with a shorter duration of symptoms and may be a useful indicator of disease chronicity in the newly diagnosed child. Normal ERLs is also associated with a lower skin DAS. The lack of association between normal ERLs and other variables indicates that normal findings on nailfold capillaroscopy should not be used as justification to delay immunosuppressive therapy in children with typical symptoms of juvenile DM.
Figures
Similar articles
-
Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis.Arthritis Rheum. 2008 Feb;58(2):571-6. doi: 10.1002/art.23299. Arthritis Rheum. 2008. PMID: 18240225 Free PMC article.
-
Skin involvement in juvenile dermatomyositis is associated with loss of end row nailfold capillary loops.J Rheumatol. 2004 Aug;31(8):1644-9. J Rheumatol. 2004. PMID: 15290747
-
Improvement of nailfold capillary microangiopathy after immunosuppressant therapy in a child with clinically amyopathic juvenile dermatomyositis.Rev Bras Reumatol Engl Ed. 2017 Sep-Oct;57(5):487-490. doi: 10.1016/j.rbre.2016.05.002. Epub 2016 Jun 4. Rev Bras Reumatol Engl Ed. 2017. PMID: 29037322 English, Portuguese. No abstract available.
-
State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis.Semin Arthritis Rheum. 2017 Dec;47(3):432-444. doi: 10.1016/j.semarthrit.2017.06.001. Epub 2017 Jun 28. Semin Arthritis Rheum. 2017. PMID: 28668440 Review.
-
[Nailfold capillaroscopy in children and adolescents with rheumatic diseases].Acta Reumatol Port. 2008 Oct-Dec;33(4):395-400. Acta Reumatol Port. 2008. PMID: 19107084 Review. Portuguese.
Cited by
-
Artificial intelligence for nailfold capillaroscopy analyses - a proof of concept application in juvenile dermatomyositis.Pediatr Res. 2024 Mar;95(4):981-987. doi: 10.1038/s41390-023-02894-7. Epub 2023 Nov 22. Pediatr Res. 2024. PMID: 37993641
-
Association of nailfold capillary changes with disease activity, clinical and laboratory findings in patients with dermatomyositis.Med J Islam Repub Iran. 2015 Jul 11;29:233. eCollection 2015. Med J Islam Repub Iran. 2015. PMID: 26793626 Free PMC article.
-
Nailfold Capillaroscopy: A Promising, Noninvasive Approach to Predict Retinopathy of Prematurity.J Pediatr. 2023 Aug;259:113478. doi: 10.1016/j.jpeds.2023.113478. Epub 2023 May 12. J Pediatr. 2023. PMID: 37182664 Free PMC article.
-
Monozygotic twins discordant for juvenile dermatomyositis: clinical, serological and gene expression studies.Pediatr Rheumatol Online J. 2025 Mar 26;23(1):32. doi: 10.1186/s12969-025-01082-7. Pediatr Rheumatol Online J. 2025. PMID: 40140985 Free PMC article.
-
Clues to Disease Activity in Juvenile Dermatomyositis: Neopterin and Other Biomarkers.Diagnostics (Basel). 2021 Dec 21;12(1):8. doi: 10.3390/diagnostics12010008. Diagnostics (Basel). 2021. PMID: 35054173 Free PMC article.
References
-
- Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatrics. 2006;148:247–53. - PubMed
-
- Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: Results from the national institute of arthritis and musculoskeletal and skin diseases research registry. Arthritis Rheum. 2005;15:166–72. - PubMed
-
- Lutz J, Huwiler KG, Fedczyna T, Lechman TS, Crawford S, Kinsella TR, et al. Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis. Clinical Immunol. 2002;103:260–3. - PubMed
-
- Pachman LM, Liotta-Davis M, Hong D, Kinsella TR, Mendez E, Kinder J, Chen EH. TNFα-308A allele in juvenile dermatomyositis-association with increased TNFα production, disease duration, and pathological calcifications. Arthritis Rheum. 2000;43:2368–2377. - PubMed
-
- Feldman BM, Reed AM, Rider LG, Pachman LM. Juvenile dermatomyositis & other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371:2201–2212. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials